The Business Development Office team at Hudson Institute brings together a range of experience and skills to assist with the translation of our research. Reach out to any of us if you have queries about business development and commercialisation at Hudson Institute.

 

Mr Rob Merriel, Company Secretary at Hudson Institute of Medical ResearchRob Merriel BA, Grad Dip (Psych), Grad Dip (Accounting), CPA

Chief Commercialisation Officer (CCO)
As CCO at Hudson, Rob has an overall portfolio responsibility for the management and commercialisation of Institute IP. He has over 35 years of experience working in medical research (Baker IDI and Hudson Institute), healthcare services (Melbourne Health and Southern Health) and commercial organisations (Pacific Dunlop and Deloitte Consulting). He is currently on the Boards of two biotechnology start-up companies, is a non-Executive Director of ASX listed cancer therapeutics company Invion Limited, and has been a Director of two Venture Capital Funds and a Director and Company Secretary of several biotechnology-focused medical research institute spin off companies.

Further, Rob has been the Hudson Institute lead in attracting three separate multi-million dollar investments in the translation of discovery science into new treatments for patients: Investments from Roche Pharmaceuticals, from a Boston based Venture Capital fund and from an Australian Venture Capital fund.

 

Carmela Monger, Patent Attorney, BSc, MSc, GAICD

Business Development Manager
Carmela brings more than 23 years’ experience managing the intellectual property portfolios for businesses in private practice and medical research to Hudson Institute, including oversight of the strategic commercialisation of technologies in Australia and overseas. Carmela is a registered patent attorney and graduate of the Australian Institute of Company Directors. She was recently a Director of Nexpep Pty Ltd and the Victorian Cancer Biobank. She has secured high-value license deals with pharma, venture capital and biotech and was actively involved in a landmark monetisation deal at the Walter and Eliza Hall Institute.

At Hudson, Carmela manages and contributes to a range of activities including intellectual property management, opportunity identification and analysis, research and marketing of commercial projects, investor and partner relations, commercial agreements and technology transfer.

 

Kate Mackin BA, BSc(Hons), PhD

Business Development Coordinator
Kate comes from a research background, attaining her PhD in microbiology from Monash University and working as a postdoctoral research officer before joining Hudson Institute. Her previous experience also includes roles in teaching, grants, and administration within the medical research sector.

Kate joined Hudson Institute’s Business Development Office to support the commercialisation of promising inventions from the Institute’s research staff. She contributes across the spectrum of office activities, including invention disclosure assessments, proposal and contract preparation, marketing and communications, technology transfer, education and intellectual property management.